Insider Transactions in Q2 2024 at Privia Health Group, Inc. (PRVA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
Adam Boehler Director |
BUY
Open market or private purchase
|
Indirect |
364
+0.01%
|
$5,824
$16.5 P/Share
|
|
May 29
2024
|
Adam Boehler Director |
BUY
Open market or private purchase
|
Indirect |
5,306
+0.09%
|
$84,896
$16.5 P/Share
|
|
May 24
2024
|
Adam Boehler Director |
BUY
Open market or private purchase
|
Indirect |
4,280
+0.07%
|
$68,480
$16.49 P/Share
|
|
May 23
2024
|
Adam Boehler Director |
BUY
Open market or private purchase
|
Indirect |
172,642
+2.91%
|
$2,762,272
$16.28 P/Share
|
|
May 23
2024
|
Thomas A Mc Carthy Director |
BUY
Open market or private purchase
|
Direct |
10,000
+15.97%
|
$160,000
$16.37 P/Share
|
|
May 22
2024
|
Adam Boehler Director |
BUY
Open market or private purchase
|
Indirect |
102,229
+1.8%
|
$1,635,664
$16.43 P/Share
|
|
May 22
2024
|
Jaewon Ryu Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+26.89%
|
-
|
|
May 22
2024
|
Pamela O Kimmet Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+39.12%
|
-
|
|
May 22
2024
|
Thomas A Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+20.7%
|
-
|
|
May 22
2024
|
David P King Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+24.7%
|
-
|
|
May 22
2024
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+24.7%
|
-
|
|
May 22
2024
|
Nancy G Cocozza Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+30.0%
|
-
|
|
May 22
2024
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+39.12%
|
-
|
|
May 22
2024
|
William M Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,124
+24.7%
|
-
|
|
May 21
2024
|
Adam Boehler Director |
BUY
Open market or private purchase
|
Indirect |
277,565
+4.81%
|
$4,441,040
$16.17 P/Share
|
|
May 10
2024
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,869
-5.3%
|
$235,773
$17.88 P/Share
|
|
May 10
2024
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
1,506
-1.45%
|
$25,602
$17.88 P/Share
|
|
May 10
2024
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,232
-0.86%
|
$37,944
$17.88 P/Share
|
|
Apr 30
2024
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
2,252
-2.12%
|
$40,536
$18.42 P/Share
|
|
Apr 30
2024
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,320
-0.88%
|
$41,760
$18.42 P/Share
|
|
Apr 30
2024
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,219
-4.46%
|
$219,942
$18.42 P/Share
|
|
Apr 30
2024
|
Matthew Shawn Morris Director |
SELL
Open market or private sale
|
Direct |
11,059
-13.63%
|
$199,062
$18.42 P/Share
|
|
Apr 02
2024
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,933
-1.48%
|
$66,861
$17.77 P/Share
|